Capula Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,504	Closed	-$371K	–	305
2024 Q2	$371K	Buy	+4,504	New	+$371K	﹤0.01%	212
2021 Q4	–	Sell	-2,689	Closed	-$208K	–	97
2021 Q3	$208K	Sell	2,689 -261	-9%	-$20.2K	﹤0.01%	456
2021 Q2	$246K	Buy	+2,950	New	+$246K	﹤0.01%	326